| Literature DB >> 35520166 |
Thanapon Charoenwongpaiboon1, Kantpitchar Supraditaporn2, Phatchanat Klaimon2, Karan Wangpaiboon1, Rath Pichyangkura1, Surapol Issaragrisil2, Chanchao Lorthongpanich2.
Abstract
Alternan, an α-1,3- and α-1,6-linked glucan, is a polysaccharide that is produced by bacteria. Although the structure of alternan used in this study, an α-1,3- and α-1,6-linked glucan (hereafter referred to as alternan), has been comprehensively characterized, its function on cell biology, especially relative to cell growth and differentiation, has not been fully elucidated. In this study, we set forth to compare the effect of alternan versus chitosan on the biological properties of human mesenchymal stem cells (MSCs). The effect of chitosan on MSC differentiation has already been well characterized. The treated cells were determined for cell proliferation and differentiation capacity compared to untreated cells. The result showed that treatment by alternan or chitosan increased cell proliferation, as demonstrated by increased cell number and scratched regions that were fully restored in less time than it took to fully restore controls. Further investigation found that alternan and chitosan activates the toll-like receptor (TLR) pathway suggesting that these cells may be prone to differentiation. In agreement with this result, an increase in deposited calcium was observed in alternan- or chitosan-treated cells after osteogenic differentiation induction. However, adipogenic differentiation was significantly inhibited in the presence of chitosan, but no change was observed in alternan treatment. Taken together, these results demonstrate biological effects of alternan on human MSCs. Moreover, these novel roles of alternan may have important beneficial medical applications and may provide a basis from which stem cell therapies can be developed in the future. This journal is © The Royal Society of Chemistry.Entities:
Year: 2019 PMID: 35520166 PMCID: PMC9060545 DOI: 10.1039/c8ra10263e
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Primer sequences used for quantitative real-time PCR
| Human TLR | Primers |
|---|---|
|
| 5′-TGTGAACCTCCAGGCTCTG-3′ |
| 5′-GTCCATATTTCCCACTCTCAGG-3′ | |
|
| 5′-AGCCGCCAACTTCACAAG-3′ |
| 5′-AGCTCTTGGAGATTTTCCAGC-3′ | |
|
| 5′-ACAGAAGCTGGTGGCTGTG-3′ |
| 5′-TCTTTAAATGCACCTGGTTGG-3′ |
Fig. 1Alternan isolation and preparation. (A) Synthesis of alternan using recombinant alternansucrase from Leuconostoc citreum ABK-01. (B) Solubility of alternan in nanoparticle and solution formats. (C) Mole percentage of methylated glucoses in alternan and sonicated alternan hydrolysate.
Fig. 2Effects of alternan and chitosan on MSC viability and proliferation. The viability of MSCs treated with different concentrations of (A) soluble alternan and (B) chitosan was measure by MTT assay. (C) Time course analysis for cell proliferation property after MSCs were treated with selected concentrations of alternan and chitosan for 1, 4, and 8 days. Each data point is presented as mean ± SEM. Asterisk (*) indicates significant difference between the total cell value of the treated group compared with that of the untreated group (*p < 0.05, **p < 0.01, and ***p < 0.001).
Fig. 3Effect of soluble alternan and chitosan on MSC migration. (A) Migration analysis was performed by scratch wound healing assay. (B) The distance between the edges of the scratched region measured by NIS-Elements software. Each data point is presented as mean ± SEM (*p < 0.05 vs. untreated group, **p < 0.01 vs. untreated group, and ***p < 0.001).
Fig. 4Expression profile of (A) TLR2, (B) TLR3, and (C) TLR4 of MSCs untreated and treated with chitosan (5 μg ml−1) or soluble alternan (5 and 500 μg ml−1). Each data point is presented as mean ± SEM (*p < 0.05 vs. untreated group, **p < 0.01 vs. untreated group, and ***p < 0.001).
Fig. 5Effect of soluble alternan on osteogenic (OD) and adipogenic (AD) differentiation. (A) Osteogenic differentiation of MSCs was detected by Alizarin Red S (ARS) staining, while adipogenic differentiation was detected by Oil Red O staining. (B) ARS staining was quantified by measuring the area of coloration using ImageJ software. (C) Oil Red O staining was quantified by spectrophotometer at 510 nm. Each data point is presented as mean ± SEM (*p < 0.05 vs. untreated group, **p < 0.01 vs. untreated group, and ***p < 0.001).
Selected example of glucan from different sources grouped according to structure, type and biological activity
| Glucan name/structure | Source | Animal/cell type | Biological activity | Reference |
|---|---|---|---|---|
| Alternan/(α-1,3)(α-1,6)- | Synthesis | Human mesenchymal stem cell | Increase cell proliferation | This work |
| Increase cell migration | ||||
| Increase the expression of | ||||
| Enhance osteogenic differentiation | ||||
| β-Glucan/(β-1,3)(β-1,4)- | Barley | Mouse C2C12 myoblast cell | Increase cell proliferation |
|
| Increase cell differentiation | ||||
| Decrease the fibrotic process | ||||
| 38 Mutan/(α-1,3)- |
| RAW264.7 cells | Increase osteoclast differentiation |
|
| Enhance alveolar bone loss in rat maxillae | ||||
| Increase expression of IL-1β, IL-1α, | ||||
| Dextran/((α-1,6)- | Synthesis | Primary macrophages from rats | Increase TNFα, |
|
| (α-1,6)- |
| KM mice; YAC-1 cells | Increase proliferation of spleen cells |
|
| Increase NK cell cytotoxicity | ||||
| Increase phagocytic function of MO | ||||
| Increase hemolytic activity | ||||
| Increase serum IgG | ||||
| (α-1,6)-Branched, (α-1,4)- |
| Human lymphocytes; human complement kits | Activate NK cells, T and B cells complement activation Th1 pathway-associated profile |
|
| Pullulan/α-1,6-linked maltrotiose | Unknown | Human pDC-like CAL-1 cell line | Increase the expressions of type IFN-α, IFN-β1, TNF-α, |
|